Peptides · Recovery & Longevity

Ten years ago, “peptide” was a word you’d find on a biochemistry final, somewhere between “enzyme” and the question nobody studied for.

Today it’s everywhere — in gym locker rooms, on podcasts, in med-spa ads, and, this past summer, on a federal advisory panel's agenda. One June headline reported that a peptide-based drug helped people lose about 30% of their body weight.

So what are these things? Why is everyone suddenly talking about them? And what, exactly, do they do?

Let’s set the table.

What Is a Peptide?

A peptide is a short chain of amino acids, the same building blocks that make up protein. According to the National Human Genome Research Institute, a peptide typically contains 2 to 50 amino acids linked by chemical bonds. String together 51 or more, and you have a polypeptide, the raw material proteins are built from.

Think of amino acids as letters. A protein is a full novel. A peptide is closer to a text message: short, specific, and meant to deliver one instruction.

That’s the key word. Instruction.

What Do Peptides Do?

Many peptides work as messengers. Your body makes them to tell cells what to do, such as release a hormone, adjust blood sugar, signal hunger or fullness, or kick off a repair process.

Some of the best-known molecules in modern medicine belong to this family. Insulin is a peptide hormone. So are the GLP-1 medications behind names you’ve almost certainly heard: Ozempic, Wegovy and Zepbound.

Because peptides mimic signals the body already uses, many people see them as a more targeted approach than blunt-force drugs. (That’s the appeal, anyway. Appeal and evidence are different animals, as you’ll see.)

Why Everyone Is Talking About Wellness Peptides

1. The weight-loss drugs delivered.

Approved GLP-1 drugs changed the conversation. In clinical trials summarized by Hers, semaglutide 2.4 mg was associated with about 15% average weight loss over 68 weeks, and tirzepatide 15 mg with about 21% over 72 weeks.*

Then came retatrutide. UCHealth reported in June 2026 that trial volunteers lost an average of about 70 pounds, or roughly 30% of body weight, over 80 weeks.* More than 45% of participants lost more than 30%. For comparison, UCHealth puts typical weight loss from bariatric surgery at about 20% to 25%.

Retatrutide, which is still in trials and not yet FDA-approved, is a “triple agonist.” It targets three hormone pathways at once: GLP-1, GIP, and glucagon.

Dr. Low Wang also told UCHealth that researchers don’t yet fully understand why that three-way combination is so effective. Science, it turns out, sometimes gets the answer before it gets the explanation.

2. The fitness crowd found them.

Away from the pharmacy counter, compounds like BPC-157 and TB-500 have built a devoted following in fitness and biohacking circles for their perceived ability to help tendons, muscles, and joints recover.* Much of that enthusiasm has spread by word of mouth, gym to gym and podcast to podcast.

Longevity is the newest frontier, and the most speculative. GHK-Cu, a copper-binding peptide found naturally in blood, falls from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60, which is one reason researchers are studying it for aging skin and tissue repair. So far, most of that work involves topical use and lab studies.

3. Washington got involved.

In April 2026, the FDA said it would remove 12 peptides from its “Category 2” list, a group of compounding substances flagged for significant safety concerns. Then, on July 23, the agency’s Pharmacy Compounding Advisory Committee voted 8-6, with one abstention, to recommend BPC-157, KPV and TB-500 for the list of substances pharmacies may compound.*

Did you catch the margin? Eight to six. FDA staff scientists had recommended against all seven peptides under review. They found that the available human studies of BPC-157 were short, small, and insufficient to establish safety or effectiveness. The committee’s vote is a nonbinding recommendation. The FDA must still accept it and complete formal rulemaking before compounding pharmacies could legally prepare these peptides for patients.

Few things signal “this is going mainstream” as much as a federal docket number.

What This Means for You

Here’s the part that rarely makes the highlight reel: “peptide” is a category, not a quality grade.

Insulin is a peptide. So is whatever is inside a vial labeled “for research use only” and sold from a website with a countdown timer. One of those has roughly a century of clinical paperwork behind it. The other, by its own label, is not intended for people.

Approved peptide medicines have gone through clinical trials and FDA review for specific uses. Many of the trending compounds you hear about at the gym have not, at least not yet. That doesn’t make them useless. It means the evidence is uneven, and uneven evidence deserves a careful look before anyone acts on it.

So the smart question isn’t “Do peptides work?” It’s “Which peptide, for what purpose, and backed by how much evidence?” Ask your health care provider that. Ask it of every headline, too.

Including that 30% one.

After all, a peptide is a message. Before you act on a message, it helps to know who sent it and what they actually said.

Read the full UCHealth report behind the 30% retatrutide headline.

Frequently Asked Questions About Wellness Peptides